Table 4. Correlation of the variable LDH level with the clinicopathological characteristics of SCLC patients.
| Variable | LDH (U/L) | ||
|---|---|---|---|
| ≤216.5n (%) | >216.5n (%) | p value | |
| Age (years) | 0.051 | ||
| ≤65 | 418(74.5) | 143(25.5) | |
| >65 | 97(66.4) | 49(33.6) | |
| Gender | 0.449 | ||
| Male | 335(73.8) | 119(26.2) | |
| Female | 180(71.1) | 73(28.9) | |
| KPS | 0.274 | ||
| >80 points | 401(73.8) | 142(26.2) | |
| ≤80 points | 114(69.5) | 50(30.5) | |
| Smoking history | 0.224 | ||
| Yes | 315(71.3) | 127(28.7) | |
| No | 200(75.5) | 65(24.5) | |
| Anemia | 0.025 | ||
| Yes | 39(60.9) | 25(39.1) | |
| No | 476(74.0) | 167(26.0) | |
| Lymphocyte(×109/L) | 0.426 | ||
| ≤1.65 | 267(71.6) | 106(28.4) | |
| >1.65 | 248(74.3) | 86(25.7) | |
| NLR | 0.001 | ||
| ≤3.18 | 356(77.1) | 106(22.9) | |
| >3.18 | 159(64.9) | 86(35.1) | |
| LMR | <0.001 | ||
| ≤2.615 | 113(57.9) | 82(42.1) | |
| >2.615 | 402(78.5) | 110(21.5) | |
| ALP (U/L) | 0.003 | ||
| ≤119.5 | 413(75.5) | 134(24.5) | |
| >119.5 | 102(63.8) | 58(36.2) | |
| Stage | <0.001 | ||
| LD | 348(83.1) | 71(16.9) | |
| ED | 167(58.0) | 121(42.0) | |
| Metastatic sites | <0.001 | ||
| <2 | 486(75.7) | 156(24.3) | |
| ≥2 | 29(44.6) | 36(55.4) | |